A groundbreaking revelation from researchers at Doshisha University, Japan, has ...
In recent years, advancements in personalized medicine have extended into the re...
In the arid and nutrient-poor landscapes of southwestern Australia thrives a rem...
In the relentless battle against advanced non-small-cell lung cancer (NSCLC) har...
In recent years, cold exposure has emerged as a popular topic within the realms ...
In a comprehensive new investigation unveiled at the European Stroke Organisatio...
Imagine a world where we can monitor the molecular landscape of our bodies in re...
The Food and Drug Administration (FDA) has introduced more rigorous regulatory r...
Boehringer Ingelheim’s presentation of phase 3 data for its idiopathic pulmonary...
CellCentric, a UK-based biotechnology company backed by Pfizer, has raised $120 ...
In a major breakthrough, researchers have uncovered a potential way to stop canc...
Moderna has announced that it is withdrawing its application for approval from t...
BioNTech has entered a grant agreement with the UK government to expand its rese...
Orionis Biosciences has announced a multi-year partnership with Roche’s Genentec...
After the FDA asked for more clinical data in May 2025, Moderna has decided to r...
Potential US pharma import tariffs could raise prices, stifle innovation, and re...
